The case against Medtronic alleges the company manufactured defective defibrillation leads that led to the deaths of at least 13 people who received the implants. Following this incident, Medtronic recalled the product. Under the terms of the agreement, Medtronic will pay $268 million and all multi-district litigations and state court proceedings related to this case will be terminated. The plaintiff’s pending appeals will also be dismissed, according to the news release.
As part of the settlement, Medtronic is not admitting any liability.
Read the news release about Medtronic’s settlement.
Read other coverage about settlements:
– St. Louis-Area Internist, Employer to Pay $1.6M to Settle Medicare Fraud Case
– Medical Device Maker, Government Reach Tentative $10M Settlement for Alleged Kickback Scheme
– CHRISTUS Health in Houston to Pay $1M Settlement in Medicare Fraud Lawsuit
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
